China Targets Pharma Distribution Revamp Via New Good Supply Practices
This article was originally published in PharmAsia News
Executive Summary
A China FDA official said the new good supply practices (GSP) has no target number for eliminating pharma distributors, but instead it aims to shift resources to large companies from outdated and smaller competitors.